Improving National Laboratory Capability and Capacity to Measure Human Exposure to Synthetic Opioids
RTI International Forensic Technology Center of Excellence webinar (host) · February 4, 2026
CDC presenter Dr. Rudolph Johnson outlined new reference-material kits and testing resources intended to improve U.S. laboratory capacity to detect synthetic opioids, described gaps in immunoassay cross-reactivity for fentanyl analogs, and answered attendee questions about instrumentation and kit use.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No transcript available.
No outline available for this source.
No related articles available for this source.
No highlights available for this source.
No claims available for this source.
No actions available for this source.
No topics available for this source.
No clarifying details available for this source.
No discussions available for this source.
No community relevance data available for this source.
No funding sources available for this source.
No speakers available for this source.
No transcript available for this source.